Press release
A New Market Study on Singapore Over the Counter (OTC) Drugs Industry
Browse And Choose From Our World Class Research Reports
View Report at “http://www.marketdataforecast.com/market-reports/singapore-over-the-counter-drugs-market-801/”
Singapore Over the Counter Drugs market has a share of 1.2 % of total Asia-Pacific OTC market. The term ‘’Over the counter’’ refers to pharmaceuticals, that are bought across the counter without any prescription from physicians. Availability, Affordability, Trust, and Empowerment are the four aspects epitomize the value of OTC drugs that provide consumers and healthcare system of a nation. The rapid growth of the aging population is one of the major reason for the growth of OTC Drug market.
Request for free sample report at “http://www.marketdataforecast.com/market-reports/singapore-over-the-counter-drugs-market-801/request-sample”
Major factors that are influencing the growth of the market are Cost-aware insurance programs, increasing pressure from the customers, drug manufacturers to redevelop prescription drugs to over the counter drugs. The major problem that is restraining the growth of the market is cost sensitivity of production.
Product Segmentation:
Based on Formulation:
-Tablets
-Liquids
-Ointments
-Sprays
Based on Product type:
-Cough, Cold and Flu Drugs
-Analgesics
-Dermatologists
-Gastrointestinal Drugs
-Antiseptics
-Anti-Allergy Drugs
-Smoking Cessation Aids
-Ophthalmic
-Vitamins and Minerals
-Sleep Aids
-Weight Loss/Diet Drugs
-Others (Ear Drops & Diuretics)
Based on distribution channels:
-Pharmacies/Drug Stores
-Supermarkets/Hypermarkets
-Convenience Stores
-Others (Online Drugstores)
Key players influencing Over the Counter Drugs Market in Singapore are Eu Yan Sang international Ltd, Bayer AG, Johnson & Johnson, Glaxo SmithKline plc, Merck Pte Ltd, Sunward Pharmaceutical Pte Ltd, Beacons Pharmaceuticals (Pte) Ltd.
About:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Contact:
Market Data Forecast, Inc.
+1-888-702-9626 (U.S. TOLL-FREE)
contact@marketdataforecast.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release A New Market Study on Singapore Over the Counter (OTC) Drugs Industry here
News-ID: 387719 • Views: …
More Releases from Market Data Forecast
Middle East and Africa Steel Rebar Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the middle east steel rebar market was worth US$ 8.59 billion in 2023 and is anticipated to reach a valuation of US$ 13.19 billion by 2029 and it is predicted to register a CAGR of 7.4% during the forecast period 2024-2029.
the Middle East is driving strong demand for steel rebar, the backbone of reinforced concrete. This growth is fueled…
Middle East and Africa Industrial Lubricants Market Share, Industry Analysis & F …
According to the latest research report published by Market Data Forecast, the middle east and africa industrial lubricants market was worth US$ 18.51 billion in 2023 and is anticipated to reach a valuation of US$ 22.62 billion by 2029 and it is predicted to register a CAGR of 3.4% during the forecast period 2024-2029.
Industrial lubricants in the Middle East and Africa are specialized substances vital for reducing friction and wear…
Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2 …
According to the latest research report published by Market Data Forecast, the global steam methane reforming market size was valued at USD 691.67 million in 2023 and is projected to reach USD 1004.13 million by 2029, growing at a CAGR of 6.41% during the forecast period 2024 to 2029.
Steam reforming of methane mainly involves two reactions: the water gas shift reaction and the reforming reaction. In the latter case, natural…
Telecom Tower Market is set for a Potential Growth
According to the latest research report published by Market Data Forecast, the global telecom tower market is predicted to reach USD 3.74 billion in 2024 and USD 7.07 billion by 2029, growing at a CAGR of 13.59% during the forecast period.
Telecom towers are the backbone of any mobile telecommunications system. The telecom tower is a structure that houses a transceiver to maintain connection with thousands of mobile phones and the…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
